Oriol Manuel

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


238 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | ...
In press
 
Initial empirical antibiotic therapy in kidney transplant recipients with pyelonephritis: A global survey of current practice and opinions across 19 countries on six continents.
Coussement J., Bansal S.B., Scemla A., Svensson MHS, Barcan L.A., Smibert O.C., Clemente W.T., Lopez-Medrano F., Hoffman T., Maggiore U. et al. Transplant infectious disease. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_69A18D4EB6A9]
 
Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis
Halfon Matthieu, Taffé Patrick, Bucher Christian, Haidar Fadi, Huynh-do Uyen, Mani Laila-Yasmin, Schachtner Thomas, Wehmeier Caroline, Venetz Jean-Pierre, Pascual Manuel et al. Kidney International Reports.
[DOI][serval:BIB_D7E82EDAEFE7]
 
BK Polyomavirus (BKPyV) Serotype-Specific Antibody Responses in Blood Donors and Kidney Transplant Recipients with and without new-onset BKPyV-DNAemia: A Swiss Transplant Cohort Study.
Hillenbrand C.A., Bani D.A., Follonier O., Kaur A., Weissbach F.H., Wernli M., Wilhelm M., Leuzinger K., Binet I., Bochud P.Y. et al. American journal of transplantation. Peer-reviewed.
[DOI][Pmid][serval:BIB_B490BDD28908]
 
Clinical Management and Outcomes of Nontuberculous Mycobacterial Infections in Solid Organ Transplant Recipients: A Multinational Case-control Study.
López-Medrano F., Carver P.L., Rutjanawech S., Aranha-Camargo L.F., Fernandes R., Belga S., Daniels S.A., Mueller N.J., Burkhard S., Theodoropoulos N.M. et al. Transplantation. Peer-reviewed.
[DOI][Pmid][serval:BIB_D3B627A330DB]
2024
 
Donor-derived infections: The Swiss perspective.
Mueller N.J., Manuel O., Hirzel C., Swiss Transplant Cohort Study (STCS), 2024/11. Transplant infectious disease, 26 (Suppl 1) pp. e14314. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FEC2BB4EB150]
 
Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study.
Amstutz A., Chammartin F., Audigé A., Eichenberger A.L., Braun D.L., Amico P., Stoeckle M.P., Hasse B., Papadimitriou-Olivgeris M., Manuel O. et al., 2024/10/16. The Journal of infectious diseases, 230 (4) pp. e847-e859. Peer-reviewed.
[DOI][Pmid][serval:BIB_3D75BC1FB104]
 
Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study.
Kusejko K., Kouyos R.D., Bernasconi E., Boggian K., Braun D.L., Calmy A., Cavassini M., van Delden C., Furrer H., Garzoni C. et al., 2024/10/11. BMC infectious diseases, 24 (1) p. 1143. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5687AF8C12A6]
 
Prognostic role of early blood gas variables in critically ill patients with Pneumocystis jirovecii pneumonia: a retrospective analysis.
Voutaz A., Bonnemain J., Ltaief Z., Manuel O., Liaudet L., 2024/09/27. Critical care, 28 (1) p. 318. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ED4FC40E9888]
 
Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum.
Ljungman P., Chemaly R.F., Khawaya F., Alain S., Avery R., Badshah C., Boeckh M., Fournier M., Hodowanec A., Komatsu T. et al., 2024/09/26. Clinical infectious diseases, 79 (3) pp. 787-794. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B2FFDC3344BC]
 
Clinical manifestations and immune markers of non-HIV-related CMV retinitis.
Passarin O., Hoogewoud F., Manuel O., Guex-Crosier Y., 2024/08/06. BMC infectious diseases, 24 (1) p. 787. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5F3CE597735B]
 
Antifungal drug penetration in soft tissue abscesses: a comparative analysis.
Cancela Costa A., Kritikos A., Glampedakis E., Da Silva Pereira Clara J., Schaller F., Mercier T., Strasser R., Balmpouzis Z., Koutsokera A., Manuel O. et al., 2024/07/01. The Journal of antimicrobial chemotherapy, 79 (7) pp. 1668-1672. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_94BC817AB3D7]
 
Surgical site infections after kidney transplantation are independently associated with graft loss.
Schreiber P.W., Hoessly L.D., Boggian K., Neofytos D., van Delden C., Egli A., Dickenmann M., Hirzel C., Manuel O., Koller M. et al., 2024/05. American journal of transplantation, 24 (5) pp. 795-802. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5E28895E3E42]
 
Infections respiratoires : quand un cheval est en fait un zèbre [Respiratory infections: when a horse is actually a zebra]
Cancela Costa A., Cobuccio L., Monsalve L., Pallanza M., Teixeira Antunes A., Manuel O., Desgranges F., 2024/04/10. Revue medicale suisse, 20 (869) pp. 734-738. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1CC66F77F4B9]
 
Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020.
Hosseini-Moghaddam S.M., Kothari S., Humar A., Albasata H., Yetmar Z.A., Razonable R.R., Neofytos D., D'Asaro M., Boggian K., Hirzel C. et al., 2024/04. American journal of transplantation, 24 (4) pp. 653-668. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D83D710E76C1]
 
Current management of SARS-CoV-2 infection in solid organ transplant recipients: Experience derived from an ESGICH-ESOT survey.
Visentin A., Pickavance E., San-Juan R., Grossi P.A., Manuel O., Aguado J.M., 2024/04. Transplant infectious disease, 26 (2) pp. e14252. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1D113FA2030C]
Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized Clinical Trial.
Manuel O., Laager M., Hirzel C., Neofytos D., Walti L.N., Hoenger G., Binet I., Schnyder A., Stampf S., Koller M. et al., 2024/02/17. Clinical infectious diseases, 78 (2) pp. 312-323. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AA450EA2BB8A]
Immunogenicity of High-Dose Versus MF59-Adjuvanted Versus Standard Influenza Vaccine in Solid Organ Transplant Recipients: The Swiss/Spanish Trial in Solid Organ Transplantation on Prevention of Influenza (STOP-FLU Trial).
Mombelli M., Neofytos D., Huynh-Do U., Sánchez-Céspedes J., Stampf S., Golshayan D., Dahdal S., Stirnimann G., Schnyder A., Garzoni C. et al., 2024/01/25. Clinical infectious diseases, 78 (1) pp. 48-56. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F905F25D58E1]
 
Current Challenges and Advances on Infectious Diseases in Solid Organ Transplantation.
Fernández-Ruiz M., Giannella M., Helanterä I., Manuel O., Pierrotti L.C., Yahav D., 2024. Transplant international, 37 p. 13856. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8399F309E39F]
Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species.
Brune J.E., Dickenmann M., Sidler D., Walti L.N., Golshayan D., Manuel O., Haidar F., Neofytos D., Schnyder A., Boggian K. et al., 2024. Frontiers in medicine, 11 p. 1329778. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E14F344895B2]
 
Monocyte-derived dendritic cells can be detected in urine of kidney transplant recipients with pathogenic asymptomatic bacteriuria.
Salvadé V., Manuel O., Golshayan D., Obregon C., 2024. Frontiers in transplantation, 3 p. 1366104. Peer-reviewed.
[DOI][Pmid][serval:BIB_02C4EC74CB87]
2023
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2).
Griessbach A., Chammartin F., Abela I.A., Amico P., Stoeckle M.P., Eichenberger A.L., Hasse B., Braun D.L., Schuurmans M.M., Müller T.F. et al., 2023/11. Open forum infectious diseases, 10 (11) pp. ofad536. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AA0E2350DF22]
 
Burden of seasonal influenza in the Swiss adult population during the 2016/2017-2018/2019 influenza seasons.
Ammann D., Bilger J., Loiacono M.M., Oberle S.G., Dounas A., Manuel O., Pletscher M., 2023/11. Influenza and other respiratory viruses, 17 (11) pp. e13218. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4EEA6BB1732B]
Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies.
Kampouri E., Little J.S., Rejeski K., Manuel O., Hammond S.P., Hill J.A., 2023/11. Transplant infectious disease, 25 (Suppl 1) pp. e14157. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C39BE8679A61]
Impact of COVID-19 on long-term lung function in lung transplant recipients: A single-center retrospective cohort study.
Touilloux B., Papadimitriou-Olivgeris M., Bongard C., Mansouri N., Ioakeim F., Manuel O., Koutsokera A., Aubert J.D., Casutt A., 2023/10. Transplant infectious disease, 25 (5) pp. e14151. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5A6B4651FB2C]
Atypical imaging patterns during lung invasive mould diseases: lessons for clinicians.
Casutt A., Lamoth F., Lortholary O., Prior J.O., Tonglet A., Manuel O., Bergeron A., Beigelman-Aubry C., 2023/09/30. European respiratory review, 32 (169). Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_6BA7EC326862]
 
The impact of COVID-19 on long term lung function in lung transplant recipients: a single-center retrospective study
Touilloux Brice, Papadimitriou-Olivgeris Matthaios, Bongard Cédric, Mansouri Nahal, Ioakeim Foteini, Aubert John-David, Manuel Oriol, Koutsokera Angela, Casutt Alessio, 2023/09/09., ERS International Congress 2023 pp. PA3365 dans Transplantation.
[DOI][WoS][serval:BIB_57DCCABB924B]
 
'Which trial do we need? Culture of preservation fluid in abdominal organ transplant recipients' Author's reply.
Manuel O., van den Bogaart L., Mueller N.J., Neofytos D., 2023/09. Clinical microbiology and infection, 29 (9) p. 1204. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_652F3C39F71D]
 
Which trial do we need? Culture of preservation fluid in abdominal organ transplant recipients.
Manuel O., van den Bogaart L., Mueller N.J., Neofytos D., 2023/07. Clinical microbiology and infection, 29 (7) pp. 832-834. Peer-reviewed.
[DOI][Pmid][serval:BIB_6C9CC8B9F3A3]
Bacteremia During the First Year After Solid Organ Transplantation: An Epidemiological Update.
Neofytos D., Stampf S., Hoessly L.D., D'Asaro M., Tang G.N., Boggian K., Hirzel C., Khanna N., Manuel O., Mueller N.J. et al., 2023/06. Open forum infectious diseases, 10 (6) pp. ofad247. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_93C3850C4E55]
 
Solid organ transplantation: Need of a new paradigm integrating biological sex.
Rello J., Manuel O., Pont T., 2023/06. European journal of internal medicine, 112 p. 117. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E1C7AD679290]
Things We Do for No Reason™: Computed tomography of the head before lumbar puncture in low-risk adults and children.
Regina J., Manuel O., 2023/06. Journal of hospital medicine, 18 (6) pp. 534-537. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6FCD65FCA391]
Nouveautés dans la prise en charge de l’infection à cytomégalovirus chez les patients transplantés [Update on the management of cytomegalovirus infection in transplant recipients]
Neofytos D., Van Delden C., Manuel O., 2023/04/12. Revue medicale suisse, 19 (822) pp. 726-730. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_68BB8D4E0C80]
Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland.
Walti L.N., Mugglin C., Mombelli M., Manuel O., Hirsch H.H., Khanna N., Mueller N.J., Berger C., Boggian K., Garzoni C. et al., 2023/04/03. JAMA network open, 6 (4) pp. e2310687. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8F026B83CBA0]
 
Preemptive therapy versus universal prophylaxis: Time for reconciliation?
Kampouri E., Manuel O., 2023/04. Transplant infectious disease, 25 (2) pp. e14014. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7331AEBBBC6E]
 
The effect of sex inequality on solid organ transplantation: A systematic review and meta-analysis.
Tejada S., Martinez-Reviejo R., Nogueira T.A., Gómez A., Pont T., Liao X., Zhang Z., Manuel O., Rello J., 2023/03. European journal of internal medicine, 109 pp. 58-67. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6D15F8F9A856]
 
Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study.
Mejia-Chew C., Carver P.L., Rutjanawech S., Camargo LFA, Fernandes R., Belga S., Daniels S.A., Müller N.J., Burkhard S., Theodoropoulos N.M. et al., 2023/02/08. Clinical infectious diseases, 76 (3) pp. e995-e1003. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0713173AF9AC]
 
Outcomes of SARS-CoV-2 infection among lung transplant recipients: A single center retrospective study.
Casutt A., Papadimitriou-Olivgeris M., Ioakeim F., Aubert J.D., Manuel O., Koutsokera A., 2023/02. Transplant infectious disease, 25 (1) pp. e14007. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B46C384138BD]
Cytomegalovirus Cell-Mediated Immunity: Ready for Routine Use?
Bestard O., Kaminski H., Couzi L., Fernández-Ruiz M., Manuel O., 2023. Transplant international, 36 p. 11963. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A3A4CB6DC8E4]
Échinococcose alvéolaire chez les receveurs d'une greffe d'organe solide : une série de cas de deux cohortes nationales [Alveolar echinococcosis in solid organ transplant recipients: a case series from two national cohorts]
Marquis B., Demonmerot F., Richou C., Thiéfin G., Millon L., Wallon M., Vuitton D.A., Grall-Jezequel A., Grenouillet F., Epaulard O. et al., 2023. Parasite, 30 p. 9. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FDE83343EF5A]
2022
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients.
Pham T.T., Andrey D.O., Stampf S., Burkhard S.H., Hirzel C., Tschopp J., Ullrich K., Strahm C., Schreiber P.W., Boillat-Blanco N. et al., 2022/12. American journal of transplantation, 22 (12) pp. 3031-3046. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FE1913230C55]
Covid-19 : quelle prise en charge pour l’automne 2022 ? [COVID-19, how to treat the disease during Fall 2022?]
Chollet V., Manuel O., De Vallière S., 2022/11/02. Revue medicale suisse, 18 (802) pp. 2077-2081. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C2059E681DC4]
 
Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell-depleting agents.
Gachoud D., Pillonel T., Tsilimidos G., Battolla D., Dumas D., Opota O., Fontana S., Vollenweider P., Manuel O., Greub G. et al., 2022/11. British journal of haematology, 199 (4) pp. 549-559. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_801AF06A907A]
Antimicrobial stewardship programs in solid-organ transplant recipients in Switzerland.
Bielicki J.A., Manuel O., Swiss Transplant Cohort Study (STCS), 2022/10. Transplant infectious disease, 24 (5) pp. e13902. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3CB8680333C5]
Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort Study.
Schreiber P.W., Laager M., Boggian K., Neofytos D., van Delden C., Egli A., Dickenmann M., Hirzel C., Manuel O., Koller M. et al., 2022/10. The Journal of hospital infection, 128 pp. 47-53. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0CFE763A8A63]
Immunocompromised patients have been neglected in COVID-19 trials: a call for action.
Trøseid M., Hentzien M., Ader F., Cardoso S.W., Arribas J.R., Molina J.M., Mueller N., Hites M., Bonnet F., Manuel O. et al., 2022/09. Clinical microbiology and infection, 28 (9) pp. 1182-1183. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_10D3D245DD24]
Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study.
Hirzel C., Projer L., Atkinson A., Surial B., Mueller N.J., Manuel O., Mombelli M., van Delden C., Hirsch H.H., Boggian K. et al., 2022/09/01. Transplantation, 106 (9) pp. 1875-1883. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_377ED42F9047]
Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis.
Tejada S., Martinez-Reviejo R., Karakoc H.N., Peña-López Y., Manuel O., Rello J., 2022/09. Advances in therapy, 39 (9) pp. 4037-4051. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3A7531729831]
 
Evaluating the risk of drug-drug interactions with pharmacokinetic boosters: the case of ritonavir-enhanced nirmatrelvir to prevent severe COVID-19.
Girardin F., Manuel O., Marzolini C., Buclin T., 2022/08. Clinical microbiology and infection, 28 (8) pp. 1044-1046. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_30CD844F1841]
Solid organ transplantation from donors with recent or current SARS-CoV-2 infection: A systematic review.
Martinez-Reviejo R., Tejada S., Cipriano A., Karakoc H.N., Manuel O., Rello J., 2022/08. Anaesthesia, critical care & pain medicine, 41 (4) p. 101098. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F36C7738043C]
Development and Validation of a Risk Score for Post-Transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients.
Dos Santos Q., Wareham N.E., Mocroft A., Rasmussen A., Gustafsson F., Perch M., Sørensen S.S., Manuel O., Müller N.J., Lundgren J. et al., 2022/07/04. Cancers, 14 (13) p. 3279. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3EF953BEBC36]
Central nervous system infections in solid organ transplant recipients: Results from the Swiss Transplant Cohort Study.
van den Bogaart L., Lang B.M., Rossi S., Neofytos D., Walti L.N., Khanna N., Mueller N.J., Boggian K., Garzoni C., Mombelli M. et al., 2022/07. The Journal of infection, 85 (1) pp. 1-7. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CA5A0C58D0E2]
Impact of different urinary tract infection phenotypes within the first year post-transplant on renal allograft outcomes.
Brune J.E., Dickenmann M., Wehmeier C., Sidler D., Walti L., Golshayan D., Manuel O., Hadaya K., Neofytos D., Schnyder A. et al., 2022/07. American journal of transplantation, 22 (7) pp. 1823-1833. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AF52B0435C03]
Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19.
Kritikos A., Gabellon S., Pagani J.L., Monti M., Bochud P.Y., Manuel O., Coste A., Greub G., Perreau M., Pantaleo G. et al., 2022/05/18. Viruses, 14 (5) p. 1089. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7AA364497D07]
Antibiotic Therapy for Difficult-to-Treat Infections in Lung Transplant Recipients: A Practical Approach.
van den Bogaart L., Manuel O., 2022/05/02. Antibiotics, 11 (5) p. 612. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E09CDBB50739]
 
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
WHO Solidarity Trial Consortium, 2022/05/02. Lancet (London, England).
[DOI][Pmid][serval:BIB_E7449A3BEA46]
 
Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review.
Filippidis P., Vionnet J., Manuel O., Mombelli M., 2022/05. Expert review of anti-infective therapy, 20 (5) pp. 663-680. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EBA61FD0AC5F]
Bas les masques, et après ?
Kaiser L., Vetter P., Calmy A., Manuel O., Calandra T., 2022/04/13. Revue medicale suisse, 18 (777) pp. 691-692. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7750DCA025DC]
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia.
Albasanz-Puig A., Durà-Miralles X., Laporte-Amargós J., Mussetti A., Ruiz-Camps I., Puerta-Alcalde P., Abdala E., Oltolini C., Akova M., Montejo J.M. et al., 2022/03/29. Microorganisms, 10 (4) p. 733. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A1642F8BA270]
Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients.
van den Bogaart L., Lang B.M., Neofytos D., Egli A., Walti L.N., Boggian K., Garzoni C., Berger C., Pascual M., van Delden C. et al., 2022/01. American journal of transplantation, 22 (1) pp. 199-209. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1437EFD0493F]
Kidney Transplantation in Patients With Active SARS-CoV-2 Replication: An Initial Case Series.
Halfon M., Stavart L., Venetz J.P., Manuel O., Golshayan D., 2022. Transplant international, 35 p. 10716. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BCD0452F39D6]
 
Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal Antibodies.
Papadimitriou-Olivgeris M., Cipriano A., Guggisberg N., Kroemer M., Tschopp J., Manuel O., Golshayan D., 2022. Transplant international, 35 p. 10721. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DAA0BF0F8F1C]
2021
Cohort profile: The Swiss Transplant Cohort Study (STCS): A nationwide longitudinal cohort study of all solid organ recipients in Switzerland.
Stampf S., Mueller N.J., van Delden C., Pascual M., Manuel O., Banz V., Binet I., De Geest S., Bochud P.Y., Leichtle A. et al., 2021/12/15. BMJ open, 11 (12) pp. e051176. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_83070D337875]
Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019.
Burwick R.M., Yawetz S., Stephenson K.E., Collier A.Y., Sen P., Blackburn B.G., Kojic E.M., Hirshberg A., Suarez J.F., Sobieszczyk M.E. et al., 2021/12/06. Clinical infectious diseases, 73 (11) pp. e3996-e4004. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_90F193837F76]
Precautions after vaccinating immunosuppressed patients with mRNA-based vaccines against SARS-CoV-2: does one size fit all?
Tau N., Manuel O., Rozen-Zvi B., Shargian L., Yahav D., 2021/12. Clinical microbiology and infection, 27 (12) pp. 1727-1728. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_10E04CCE3824]
Viral infections in lung transplantation.
Munting A., Manuel O., 2021/11. Journal of thoracic disease, 13 (11) pp. 6673-6694. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AFF818E6065F]
A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®.
Speich B., Chammartin F., Smith D., Stoeckle M.P., Amico P., Eichenberger A.L., Hasse B., Schuurmans M.M., Müller T., Tamm M. et al., 2021/10/21. Trials, 22 (1) p. 724. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B5A01BBEEB3D]
SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know.
Giannella M., Pierrotti L.C., Helanterä I., Manuel O., 2021/10. Transplant international, 34 (10) pp. 1776-1788. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BC93C5A203F2]
 
Seasonal trivalent inactivated influenza vaccine with topical imiquimod in immunocompromised patients: A randomized controlled trial.
Mombelli M., Hoschler K., Cavassini M., Pascual M., Manuel O., 2021/09. The Journal of infection, 83 (3) pp. 354-360. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8399DF169607]
 
Pneumocystis jirovecii Pneumonia and Use of mTOR Inhibitors in Kidney Transplantation.
Coussement J., Manuel O., 2021/08/16. Clinical infectious diseases, 73 (4) pp. 752-753. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B74D0D908233]
COVID-19 vaccination in solid-organ transplant recipients: generating new data as fast as possible, but taking clinical decisions as slow as necessary.
Manuel O., 2021/08. Clinical microbiology and infection, 27 (8) pp. 1070-1071. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CDFFD4849A22]
 
The future of SARS-CoV-2 vaccines in transplant recipients: To be determined.
Blumberg E.A., Manuel O., Sester M., Ison M.G., 2021/08. American journal of transplantation, 21 (8) pp. 2629-2630. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_167467470648]
 
Update on cytomegalovirus in transplant recipients: new agents, prophylaxis, and cell-mediated immunity.
Manuel O., Avery R.K., 2021/08/01. Current opinion in infectious diseases, 34 (4) pp. 307-313. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D416465890CE]
SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.
Meylan S., Dafni U., Lamoth F., Tsourti Z., Lobritz M.A., Regina J., Bressin P., Senn L., Grandbastien B., Andre C. et al., 2021/07/05. BMJ open, 11 (7) pp. e049232. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_471F833F0211]
Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study.
Walti L.N., Mugglin C., Sidler D., Mombelli M., Manuel O., Hirsch H.H., Khanna N., Mueller N., Berger C., Boggian K. et al., 2021/07. American journal of transplantation, 21 (7) pp. 2532-2542. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D6FA6ED1FF31]
 
Emergence of letermovir resistance in solid organ transplant recipients with ganciclovir resistant cytomegalovirus infection: A case series and review of the literature.
Hofmann E., Sidler D., Dahdal S., Bittel P., Suter-Riniker F., Manuel O., Walti L.N., Hirzel C., 2021/06. Transplant infectious disease, 23 (3) pp. e13515. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E88187EC061E]
Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study.
Mombelli M., Lang B.M., Neofytos D., Aubert J.D., Benden C., Berger C., Boggian K., Egli A., Soccal P.M., Kaiser L. et al., 2021/05. American journal of transplantation, 21 (5) pp. 1789-1800. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_62F7E74F1E7D]
 
Recent progress and remaining hurdles toward clinical xenotransplantation.
Meier RPH, Longchamp A., Mohiuddin M., Manuel O., Vrakas G., Maluf D.G., Buhler L.H., Muller Y.D., Pascual M., 2021/05. Xenotransplantation, 28 (3) pp. e12681. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3232FC94FF85]
 
Bronchial anastomosis dehiscence and stenosis caused by donor-transmitted Mycoplasma hominis infection in a lung transplant recipient: Case report and literature review.
Vecchio M., Koutsokera A., Touilloux B., Perentes J.Y., Manuel O., Noirez L., Aubert J.D., Lenoir A., 2021/04. Transplant infectious disease, 23 (2) pp. e13475. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_418461DBDCC0]
Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018.
Kohler P., Wolfensberger A., Stampf S., Brönnimann A., Boggian K., van Delden C., Favre M., Hirzel C., Khanna N., Kuster S.P. et al., 2021/03/07. Antimicrobial resistance and infection control, 10 (1) p. 50. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_23A5D4CD5C8E]
Impact of COVID-19 in solid organ transplant recipients.
Danziger-Isakov L., Blumberg E.A., Manuel O., Sester M., 2021/03. American journal of transplantation, 21 (3) pp. 925-937. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_63CA0A52C8CD]
 
Understanding rare infections post-lung transplantation.
van den Bogaart L., Cipriano A., Koutsokera A., Manuel O., 2021/03. Expert review of respiratory medicine, 15 (3) pp. 325-338. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C445B7ADA73E]
 
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
WHO Solidarity Trial Consortium, Pan H., Peto R., Henao-Restrepo A.M., Preziosi M.P., Sathiyamoorthy V., Abdool Karim Q., Alejandria M.M., Hernández García C., Kieny M.P. et al., 2021/02/11. The New England Journal of Medicine, 384 (6) pp. 497-511. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_AE3C5BFF9D70]
Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study.
Perrottet N., Fernández-Ruiz M., Binet I., Dickenmann M., Dahdal S., Hadaya K., Müller T., Schaub S., Koller M., Rotman S. et al., 2021. PloS one, 16 (4) pp. e0250829. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8D676A182CA8]
Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.
Bibert S., Guex N., Lourenco J., Brahier T., Papadimitriou-Olivgeris M., Damonti L., Manuel O., Liechti R., Götz L., Tschopp J. et al., 2021. Frontiers in immunology, 12 p. 666163. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_91CEC9119F7E]
2020
 
Asymptomatic bacteriuria and urinary tract infections in kidney transplant recipients.
Coussement J., Kaminski H., Scemla A., Manuel O., 2020/12. Current opinion in infectious diseases, 33 (6) pp. 419-425. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9D8E3F0264D9]
 
Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020.
Lortholary O., Fernandez-Ruiz M., Baddley J.W., Manuel O., Mariette X., Winthrop K.L., 2020/12. Annals of the rheumatic diseases, 79 (12) pp. 1532-1543. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_84459E57580F]
Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study.
van Delden C., Stampf S., Hirsch H.H., Manuel O., Meylan P., Cusini A., Hirzel C., Khanna N., Weisser M., Garzoni C. et al., 2020/10/23. Clinical infectious diseases, 71 (7) pp. e159-e169. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D4807130977C]
First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study.
Tschopp J., L'Huillier A.G., Mombelli M., Mueller N.J., Khanna N., Garzoni C., Meloni D., Papadimitriou-Olivgeris M., Neofytos D., Hirsch H.H. et al., 2020/10. American journal of transplantation, 20 (10) pp. 2876-2882. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_62886B377225]
 
COVID-19: A global transplant perspective on successfully navigating a pandemic.
Kumar D., Manuel O., Natori Y., Egawa H., Grossi P., Han S.H., Fernández-Ruiz M., Humar A., 2020/07. American journal of transplantation, 20 (7) pp. 1773-1779. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1C33C19476C4]
SARS-CoV-2, un point dans la tourmente [SARS-CoV-2, a point in the storm]
Tadini E., Papamidimitriou-Olivgeris M., Opota O., Moulin E., Lamoth F., Manuel O., Lhopitallier L., Jaton K., Croxatto A., Grandbastien B. et al., 2020/05/06. Revue medicale suisse, 16 (692) pp. 917-923. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_88A8DA997C5D]
Real-life food-safety behavior and incidence of foodborne infections in solid organ transplant recipients.
Lindup M., van den Bogaart L., Golshayan D., Aubert J.D., Vionnet J., Regamey J., Pascual M., Manuel O., Mombelli M., 2020/05. American journal of transplantation, 20 (5) pp. 1424-1430. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D8A5B5FDB9AB]
Infection à SARS-CoV-2 et transplantation d’organes solides [SARS-CoV-2 infection and solid organ transplantation]
Golshayan D., Aubert J.D., Hullin R., Moradpour D., Venetz J.P., Manuel O., Pascual M., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 815-818. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A2E2665FD9D7]
Risques infectieux des nouveaux biologiques immunosuppresseurs : quelles prophylaxies et quand ? [Infectious risks of new immunosuppressive biologicals : which prophylaxis and when ?]
Rochat Stettler L., Nguyen A., Manuel O., Van Delden C., 2020/04/15. Revue medicale suisse, 16 (690) pp. 724-730. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_598B6C57EC11]
 
Influenza in solid organ transplant recipients: epidemiology, management, and outcomes.
Mombelli M., Kampouri E., Manuel O., 2020/02. Expert review of anti-infective therapy, 18 (2) pp. 103-112. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3B8DD16D8B92]
 
Vitamin D deficiency is common in kidney transplant recipients, but is not associated with infections after transplantation.
Schreiber P.W., Kusejko K., Bischoff-Ferrari H.A., Boggian K., Bonani M., van Delden C., Enriquez N., Fehr T., Garzoni C., Hirsch H.H. et al., 2020/02. Clinical transplantation, 34 (2) pp. e13778. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F72A9834B808]
 
Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: An observational retrospective study.
Regina J., Papadimitriou-Olivgeris M., Burger R., Le Pogam M.A., Niemi T., Filippidis P., Tschopp J., Desgranges F., Viala B., Kampouri E. et al., 2020. PloS one, 15 (11) pp. e0240781. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BE26AADAD401]
2019
 
Immunosuppression reduction in liver and kidney transplant recipients with suspected bacterial infection: A multinational survey.
Shepshelovich D., Tau N., Green H., Rozen-Zvi B., Issaschar A., Falcone M., Coussement J., Zusman O., Manuel O., Mor E. et al., 2019/10. Transplant infectious disease, 21 (5) pp. e13134. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8D5463165545]
 
Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology.
Rammaert B., Puyade M., Cornely O.A., Seidel D., Grossi P., Husain S., Picard C., Lass-Flörl C., Manuel O., Le Pavec J. et al., 2019/10. Transplant infectious disease, 21 (5) pp. e13141. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D32E3356ED53]
 
Lack of association of Aspergillus colonization with the development of bronchiolitis obliterans syndrome in lung transplant recipients: An international cohort study.
Law N., Hamandi B., Fegbeutel C., Silveira F.P., Verschuuren E.A., Ussetti P., Chin-Hong P.V., Sole A., Holmes-Liew C.L., Billaud E.M. et al., 2019/09. The Journal of heart and lung transplantation, 38 (9) pp. 963-971. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_25D66975EAC8]
 
RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Manuel O., Estabrook M., American Society of Transplantation Infectious Diseases Community of Practice, 2019/09. Clinical transplantation, 33 (9) pp. e13511. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_917F5AC64A89]
 
Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report.
Duss F.R., Garcia de la Mària C., Croxatto A., Giulieri S., Lamoth F., Manuel O., Miró J.M., 2019/09/01. The Journal of antimicrobial chemotherapy, 74 (9) pp. 2626-2630. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2B99F3F57E16]
 
Different impact of rATG induction on CMV infection risk in D+R- and R+ KTRs.
Kaminski H., Jarque M., Halfon M., Taton B., Di Ascia L., Pfirmann P., Visentin J., Garrigue I., Déchanet-Merville J., Moreau J.F. et al., 2019/07/31. The Journal of infectious diseases, 220 (5) pp. 761-771. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3FA288C9277D]
 
Clinical relevance of preservation-fluid contamination in solid-organ transplantation: a call for mounting the evidence.
Yahav D., Manuel O., 2019/05. Clinical microbiology and infection, 25 (5) pp. 536-537. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_87BFEC927FCB]
Swiss Recommendations for Adult Cystic Fibrosis Care: Burkholderia cepacia complex
Sauty Alain, Manuel Oriol, Koutsokera Angela, Tullis Elizabeth, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_930B3358F5E7]
Swiss Recommendations for Adult Cystic Fibrosis Care: Other relevant bacteria (Bordetella species)
Koutsokera Angela, Manuel Oriol, Sauty Alain, Müller Nicolas, Benden Christian, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_A4107A569CBF]
Swiss Recommendations for Adult Cystic Fibrosis Care: Staphylococcus aureus
Sauty Alain, Manuel Oriol, Koutsokera Angela, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_766A09033B27]
Swiss Recommendations for Adult Cystic Fibrosis Care: Vaccination
Manuel Oriol, Koutsokera Angela, Sauty Alain, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_AE9C6040100D]
Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients.
Quteineh L., Wójtowicz A., Bochud P.Y., Crettol S., Vandenberghe F., Venetz J.P., Manuel O., Golshayan D., Lehmann R., Mueller N.J. et al., 2019/01. American journal of transplantation, 19 (1) pp. 238-246. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6D920C4CDD77]
 
Vitamin D status and risk of infections after liver transplantation in the Swiss Transplant Cohort Study.
Schreiber P.W., Bischoff-Ferrari H.A., Boggian K., van Delden C., Enriquez N., Fehr T., Garzoni C., Hirsch H.H., Hirzel C., Manuel O. et al., 2019/01. Transplant international, 32 (1) pp. 49-58. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8EEF7FDA7F91]
2018
Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
Neofytos D., Hirzel C., Boely E., Lecompte T., Khanna N., Mueller N.J., Boggian K., Cusini A., Manuel O., van Delden C. et al., 2018/12. Transplant infectious disease, 20 (6) pp. e12984. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B857EB67958D]
 
Clinical risk factors for invasive aspergillosis in lung transplant recipients: Results of an international cohort study.
Aguilar C.A., Hamandi B., Fegbeutel C., Silveira F.P., Verschuuren E.A., Ussetti P., Chin-Hong P.V., Sole A., Holmes-Liew C., Billaud E.M. et al., 2018/10. The Journal of heart and lung transplantation, 37 (10) pp. 1226-1234. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3C0C3F56A882]
 
Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial.
Mombelli M., Rettby N., Perreau M., Pascual M., Pantaleo G., Manuel O., 2018/10/01. Vaccine, 36 (41) pp. 6163-6169. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_38C298B3CEB2]
 
Diagnosis and management of asymptomatic bacteriuria in kidney transplant recipients: a survey of current practice in Europe.
Coussement J., Maggiore U., Manuel O., Scemla A., López-Medrano F., Nagler E.V., Aguado J.M., Abramowicz D., European Renal Association-European Dialysis Transplant Association (ERA-EDTA) Developing Education Science and Care for Renal Transplantation in European States (DESCARTES) working group and the European Study Group for Infections in Compromised Hosts (E, COLLABORATORS (IN ALPHABETICAL ORDER) et al., 2018/09/01. Nephrology, dialysis, transplantation, 33 (9) pp. 1661-1668. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_56C54325FA29]
 
Clinical significance of post-prophylaxis cytomegalovirus infection in lung transplant recipients.
Jaamei N., Koutsokera A., Pasquier J., Mombelli M., Meylan P., Pascual M., Aubert J.D., Manuel O., 2018/08. Transplant infectious disease, 20 (4) pp. e12893. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_53680F51E25F]
 
Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study.
Neofytos D., Chatzis O., Nasioudis D., Boely Janke E., Doco Lecompte T., Garzoni C., Berger C., Cussini A., Boggian K., Khanna N. et al., 2018/08. Transplant infectious disease, 20 (4) pp. e12898. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B74350F70BA5]
Toxoplasmosis in Transplant Recipients, Europe, 2010-2014.
Robert-Gangneux F., Meroni V., Dupont D., Botterel F., Garcia JMA, Brenier-Pinchart M.P., Accoceberry I., Akan H., Abbate I., Boggian K. et al., 2018/08. Emerging infectious diseases, 24 (8) pp. 1497-1504. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_240DB6E502F5]
Clostridium difficile infection is associated with graft loss in solid organ transplant recipients.
Cusini A., Béguelin C., Stampf S., Boggian K., Garzoni C., Koller M., Manuel O., Meylan P., Mueller N.J., Hirsch H.H. et al., 2018/07. American journal of transplantation, 18 (7) pp. 1745-1754. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_10C3CE32D79C]
 
Editorial for ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective.
Aguado J.M., Manuel O., 2018/06. Clinical microbiology and infection, 24 Suppl 2 pp. S1. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ECD0BCBB110C]
 
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors).
Redelman-Sidi G., Michielin O., Cervera C., Ribi C., Aguado J.M., Fernández-Ruiz M., Manuel O., 2018/06. Clinical microbiology and infection, 24 Suppl 2 pp. S95-S107. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_679ECFFACD23]
 
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction).
Fernández-Ruiz M., Meije Y., Manuel O., Akan H., Carratalà J., Aguado J.M., Delaloye J., 2018/06. Clinical microbiology and infection, 24 Suppl 2 pp. S2-S9. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5BE57AF16918]
 
LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions.
Yu K., Davidson C.L., Wójtowicz A., Lisboa L., Wang T., Airo A.M., Villard J., Buratto J., Sandalova T., Achour A. et al., 2018/04/02. The Journal of clinical investigation, 128 (4) pp. 1523-1537. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_97CBFEE1AA23]
 
Immune Monitoring for CMV in Transplantation.
Yong M.K., Lewin S.R., Manuel O., 2018/03/14. Current infectious disease reports, 20 (4) p. 4. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9FFC82C9824A]
Microbial metagenome of urinary tract infection.
Moustafa A., Li W., Singh H., Moncera K.J., Torralba M.G., Yu Y., Manuel O., Biggs W., Venter J.C., Nelson K.E. et al., 2018/03/12. Scientific reports, 8 (1) p. 4333. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AECBEE909C27]
Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study.
Chatzis O., Darbre S., Pasquier J., Meylan P., Manuel O., Aubert J.D., Beck-Popovic M., Masouridi-Levrat S., Ansari M., Kaiser L. et al., 2018/03/06. BMC infectious diseases, 18 (1) p. 111. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8C5CB4E6E122]
Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation.
López-Medrano F., Fernández-Ruiz M., Silva J.T., Carver P.L., van Delden C., Merino E., Pérez-Saez M.J., Montero M., Coussement J., de Abreu Mazzolin M. et al., 2018/02. Clinical microbiology and infection, 24 (2) pp. 192-198. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3DD38C51841F]
 
Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors: Latin America.
Clemente W.T., Pierrotti L.C., Abdala E., Morris M.I., Azevedo L.S., López-Vélez R., Cuenca-Estrella M., Torre-Cisneros J., Petersen E., Camargo LFA et al., 2018/02. Transplantation, 102 (2) pp. 193-208. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_638F4934C11E]
 
Vaccine Recommendations for Solid-Organ Transplant Recipients and Donors.
Stucchi RSB, Lopes M.H., Kumar D., Manuel O., 2018/02. Transplantation, 102 (2S Suppl 2) pp. S72-S80. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_41CE1036D496]
Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation.
Schreiber P.W., Bischoff-Ferrari H.A., Boggian K., Bonani M., van Delden C., Enriquez N., Fehr T., Garzoni C., Hirsch H.H., Hirzel C. et al., 2018. PloS one, 13 (1) pp. e0191167. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3A909E201383]
Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland.
Steiner R., Kridel R., Giostra E., McKee T., Achermann R., Mueller N., Manuel O., Dickenmann M., Schuurmans M.M., de Leval L. et al., 2018. Swiss medical weekly, 148 pp. w14596. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F9A10A21BBA0]
 
Voriconazole and squamous cell carcinoma after lung transplantation: A multicenter study.
Hamandi B., Fegbeutel C., Silveira F.P., Verschuuren E.A., Younus M., Mo J., Yan J., Ussetti P., Chin-Hong P.V., Solé A. et al., 2018/01. American journal of transplantation, 18 (1) pp. 113-124. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F5368ED34653]
2017
 
Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.
Navarro D., San-Juan R., Manuel O., Giménez E., Fernández-Ruiz M., Hirsch H.H., Grossi P.A., Aguado J.M., ESGICH CMV Survey Study Group on behalf of the European Study Group of Infections in Compromised Hosts (ESGICH) from the Society of Clinical Microbiology and Infectious Diseases (ESCMID), 2017/12. Transplant infectious disease, 19 (6) p. 1. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2325BFD44A4C]
BK Polyomavirus-Specific 9mer CD8 T Cell Responses Correlate With Clearance of BK Viremia in Kidney Transplant Recipients: First Report From the Swiss Transplant Cohort Study.
Leboeuf C., Wilk S., Achermann R., Binet I., Golshayan D., Hadaya K., Hirzel C., Hoffmann M., Huynh-Do U., Koller M.T. et al., 2017/10. American journal of transplantation, 17 (10) pp. 2591-2600. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9BFE3E689546]
Preventive Strategies Against Cytomegalovirus and Incidence of α-Herpesvirus Infections in Solid Organ Transplant Recipients: A Nationwide Cohort Study.
Martin-Gandul C., Stampf S., Héquet D., Mueller N.J., Cusini A., van Delden C., Khanna N., Boggian K., Hirzel C., Soccal P. et al., 2017/07. American journal of transplantation, 17 (7) pp. 1813-1822. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_19E462B2BC1D]
 
Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study.
Lebeaux D., Freund R., van Delden C., Guillot H., Marbus S.D., Matignon M., Van Wijngaerden E., Douvry B., De Greef J., Vuotto F. et al., 2017/05/15. Clinical infectious diseases, 64 (10) pp. 1396-1405. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9E6DAD557486]
 
Toxocarose : une maladie négligée en Suisse ? [Toxocariasis, a neglected disease in Switzerland ?]
Duréault A., Perez Valdes C., Weber L., Ogna A., Sempoux C., Manuel O., Delaloye J., 2017/04/12. Revue medicale suisse, 13 (558) pp. 815-819. Peer-reviewed.
[Pmid][serval:BIB_F71BB5DC77BB]
 
Human MicroRNA Responses Predict Cytomegalovirus Replication Following Solid Organ Transplantation.
Han S.H., Kumar D., Ferreira V.H., Egli A., Hirsch H.H., Weisser M., Garzoni C., van Delden C., Bochud P.Y., Manuel O. et al., 2017/02/15. The Journal of infectious diseases, 215 (4) pp. 537-546. Peer-reviewed.
[DOI][Pmid][serval:BIB_016895B6CF25]
Rapid adaptation drives invasion of airway donor microbiota by Pseudomonas after lung transplantation.
Beaume M., Köhler T., Greub G., Manuel O., Aubert J.D., Baerlocher L., Farinelli L., Buckling A., van Delden C., Swiss Transplant Cohort Study, 2017/01/17. Scientific reports, 7 p. 40309. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A067B4F4ADC7]
CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.
Quteineh L., Bochud P.Y., Golshayan D., Crettol S., Venetz J.P., Manuel O., Kutalik Z., Treyer A., Lehmann R., Mueller N.J. et al., 2017/01. The pharmacogenomics journal, 17 (1) pp. 69-75. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_342B86B6E988]
2016
 
Que faire quand une pneumonie persiste? [How to handle a non-resolving pneumonia?]
Lechartier B., Prella M., Manuel O., Nicod L.P., 2016/11/16. Revue medicale suisse, 12 (539) pp. 1942-1947. Peer-reviewed.
[Pmid][serval:BIB_429660D8230E]
 
Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study.
López-Medrano F., Fernández-Ruiz M., Silva J.T., Carver P.L., van Delden C., Merino E., Pérez-Saez M.J., Montero M., Coussement J., de Abreu Mazzolin M. et al., 2016/11. American journal of transplantation, 16 (11) pp. 3220-3234. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1B4EB884FDE3]
Visceral leishmaniasis in a lung transplant recipient: usefulness of highly sensitive real-time polymerase chain reaction for preemptive diagnosis.
Opota O., Balmpouzis Z., Berutto C., Kaiser-Guignard J., Greub G., Aubert J.D., Prod'hom G., Manuel O., Jaton K., 2016/10. Transplant infectious disease, 18 (5) pp. 801-804. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_930664C96255]
 
Oral valganciclovir for CMV gastritis.
Saouli A.C., Salvade I., Saldarriaga J., Manuel O., Venetz J.P., Golshayan D., Sempoux C., Pascual M., 2016/09. Clinics and research in hepatology and gastroenterology, 40 (4) pp. e50-1. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7E7FA851BA26]
 
HIV-Positive-to-HIV-Positive Liver Transplantation.
Calmy A., van Delden C., Giostra E., Junet C., Rubbia Brandt L., Yerly S., Chave J.P., Samer C., Elkrief L., Vionnet J. et al., 2016/08. American journal of transplantation, 16 (8) pp. 2473-2478. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_22D7E96657F8]
 
Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study.
Coussement J., Lebeaux D., van Delden C., Guillot H., Freund R., Marbus S., Melica G., Van Wijngaerden E., Douvry B., Van Laecke S. et al., 2016/08/01. Clinical infectious diseases, 63 (3) pp. 338-345. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_662F3175B8F3]
Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro.
Tschan-Plessl A., Stern M., Schmied L., Retière C., Hirsch H.H., Garzoni C., van Delden C., Boggian K., Mueller N.J., Berger C. et al., 2016/07. Transplantation direct, 2 (7) pp. e89. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_59D546BAA9DC]
Management of infections in critically ill returning travellers in the intensive care unit-II: clinical syndromes and special considerations in immunocompromised patients.
Rello J., Manuel O., Eggimann P., Richards G., Wejse C., Petersen J.E., Zacharowski K., Leblebicioglu H., ESGCIP and ESGITM, 2016/07. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 48 pp. 104-112. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A25B9CD64B78]
 
Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies.
Héquet D., Pascual M., Lartey S., Pathirana R.D., Bredholt G., Hoschler K., Hullin R., Meylan P., Cox R.J., Manuel O., 2016/06/30. Vaccine, 34 (31) pp. 3576-3583. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_131AECC2C5F7]
 
Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation.
Golshayan D., Wójtowicz A., Bibert S., Pyndiah N., Manuel O., Binet I., Buhler L.H., Huynh-Do U., Mueller T., Steiger J. et al., 2016/04. Kidney international, 89 (4) pp. 927-938. Peer-reviewed.
[DOI][Pmid][serval:BIB_8C4D147BB18F]
 
Bloodstream infections after solid-organ transplantation.
Kritikos A., Manuel O., 2016. Virulence, 7 (3) pp. 329-340. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B528B211F2C2]
 
Fatal Outcome of Multiple Clinical Presentations of Human Herpesvirus 8-related Disease After Solid Organ Transplantation.
Vijgen S., Wyss C., Meylan P., Bisig B., Letovanec I., Manuel O., Pascual M., de Leval L., 2016. Transplantation, 100 (1) pp. 134-140. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2BE89E653468]
Microbial Communities of Conducting and Respiratory Zones of Lung-Transplanted Patients.
Beaume M., Lazarevic V., Köhler T., Gaïa N., Manuel O., Aubert J.D., Baerlocher L., Farinelli L., Gasche P., Schrenzel J. et al., 2016. Frontiers in microbiology, 7 p. 1749. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E4B787656320]
Polymicrobial vertebral osteomyelitis after oesophageal biopsy: a case report.
Giger A., Yusuf E., Manuel O., Clerc O., Trampuz A., 2016. Bmc Infectious Diseases, 16 (1) p. 141. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C4CACE45B170]
Presence of Chlamydiales DNA in samples negative by broad-range bacterial 16S rRNA PCRs: new insights into chlamydial pathogenic role.
Tagini F., Jaton K., Manuel O., Greub G., 2016. New Microbes and New Infections, 11 pp. 32-33. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_4D6AFEF13D84]
 
Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case-Control Study.
López-Medrano F., Silva J.T., Fernández-Ruiz M., Carver P.L., van Delden C., Merino E., Pérez-Saez M.J., Montero M., Coussement J., de Abreu Mazzolin M. et al., 2016. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 16 (7) pp. 2148-2157. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_013465F1AEE9]
Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections.
Héquet D., Kralidis G., Carrel T., Cusini A., Garzoni C., Hullin R., Meylan P.R., Mohacsi P., Mueller N.J., Ruschitzka F. et al., 2016. Bmc Infectious Diseases, 16 p. 321. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F0F12B5AC40F]
2015
 
PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ Transplant.
Wójtowicz A., Lecompte T.D., Bibert S., Manuel O., Rüeger S., Berger C., Boggian K., Cusini A., Garzoni C., Hirsch H. et al., 2015/08/15. Clinical infectious diseases, 61 (4) pp. 619-622. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2869E1CA81A7]
 
CCL8 and the Immune Control of Cytomegalovirus in Organ Transplant Recipients.
Lisboa L.F., Egli A., Fairbanks J., O'Shea D., Manuel O., Husain S., Kumar D., Humar A., 2015. American Journal of Transplantation, 15 (7) pp. 1882-1892. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CFBFAC10D4D2]
 
CSF lactate for accurate diagnosis of community-acquired bacterial meningitis.
Giulieri S., Chapuis-Taillard C., Jaton K., Cometta A., Chuard C., Hugli O., Du Pasquier R., Bille J., Meylan P., Manuel O. et al., 2015. European Journal of Clinical Microbiology and Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, 34 (10) pp. 2049-2055. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_16CC808BB9C2]
 
Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey
San-Juan R., Manuel O., Hirsch H.H., Fernández-Ruiz M., López-Medrano F., Comoli P., Caillard S., Grossi P., Aguado J.M., 2015. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 21 (6) pp. 604.e1-604.e9. Peer-reviewed.
[DOI][Pmid][serval:BIB_21DF1D8E5474]
IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation.
Wójtowicz A., Gresnigt M.S., Lecompte T., Bibert S., Manuel O., Joosten L.A., Rüeger S., Berger C., Boggian K., Cusini A. et al., 2015. Journal of Infectious Diseases, 211 (10) pp. 1646-1657. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_06059AAED722]
 
Impact of round-the-clock CSF Gram stain on empirical therapy for suspected central nervous system infections.
Tissot F., Prod'hom G., Manuel O., Greub G., 2015. European Journal of Clinical Microbiology and Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, 34 (9) pp. 1849-1857. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_319F544687D0]
Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation.
Manuel O., Wójtowicz A., Bibert S., Mueller N.J., van Delden C., Hirsch H.H., Steiger J., Stern M., Egli A., Garzoni C. et al., 2015. Journal of Infectious Diseases, 211 (6) pp. 906-914.
[URN][DOI][WoS][Pmid][serval:BIB_653026F3E5A8]
 
Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B Haplotypes.
Schmied L., Terszowski G., Gonzalez A., Schmitter K., Hirsch H.H., Garzoni C., van Delden C., Boggian K., Mueller N.J., Berger C. et al., 2015. Transplantation, 99 (12) pp. 2651-2655. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_53EDE710E344]
 
Rapid detection of enterovirus in cerebrospinal fluid by a fully-automated PCR assay is associated with improved management of aseptic meningitis in adult patients.
Giulieri S.G., Chapuis-Taillard C., Manuel O., Hugli O., Pinget C., Wasserfallen J.B., Sahli R., Jaton K., Marchetti O., Meylan P., 2015. Journal of Clinical Virology, 62 pp. 58-62.
[DOI][WoS][Pmid][serval:BIB_1D101BF524FB]
Reply to Cunha et al.
Wójtowicz A., Lecompte T.D., Bibert S., Manuel O., Rüeger S., Berger C., Boggian K., Cusini A., Garzoni C., Khanna N. et al., 2015. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 61 (12) pp. 1894-1895. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CF730901AFF6]
 
The Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ Transplantation.
Martin-Gandul C., Mueller N.J., Pascual M., Manuel O., 2015. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 15 (12) pp. 3024-3040.
[DOI][WoS][Pmid][serval:BIB_8710031D5CD8]
 
The swiss transplant cohort study: lessons from the first 6 years.
Berger C., Bochud P.Y., Boggian K., Cusini A., Egli A., Garzoni C., Hirsch H.H., Hoffmann M., Khanna N., Manuel O. et al., 2015. Current Infectious Disease Reports, 17 (6) p. 486. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F6A008BE4476]
2014
Infections cutanées causées par des mycobactéries à croissance rapide [Skin infections due to rapid-growing mycobacteria].
Gervais P., Manuel O., Jaton K., Giulieri S., 2014/04/23. Revue Médicale Suisse, 10 (427) pp. 931-934. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_3B3C7EABD879]
 
A special issue on infections in solid organ transplant recipients.
Gavaldà J., Aguado J.M., Manuel O., Grossi P., Hirsch H.H., ESCMID Study Group of Infection in Compromised Hosts, 2014. Clinical Microbiology and Infection, 20 (Suppl 7) pp. 1-3.
[DOI][WoS][Pmid][serval:BIB_C85A454EEBDD]
 
Cytomegalovirus infection in solid organ transplant recipients
Lumbreras C., Manuel O., Len O., ten Berge I.J.M., Sgarabotto D., Hirsch H.H, 2014. Clinical Microbiology and Infection, 20 pp. 19-26.
[DOI][serval:BIB_A609887E4E1C]
 
Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment.
Stern M., Hirsch H., Cusini A., van Delden C., Manuel O., Meylan P., Boggian K., Mueller N.J., Dickenmann M., all members of the Swiss Transplant Cohort Study, 2014. Transplantation, 98 (9) pp. 1013-1018. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_703785A8005D]
 
Impact of enterococcal colonization and infection in solid organ transplantation recipients from the Swiss Transplant Cohort Study.
Bucheli E., Kralidis G., Boggian K., Cusini A., Garzoni C., Manuel O., Meylan P.R., Mueller N.J., Khanna N., van Delden C. et al., 2014. Transplant Infectious Disease : An Official Journal of the Transplantation Society, 16 (1) pp. 26-36. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D5221F95634F]
 
Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection.
Tissot F., Pascual M., Hullin R., Yerly P., Tozzi P., Meylan P., Manuel O., 2014. Transplantation, 97 (11) pp. 1192-1197.
[DOI][WoS][Pmid][serval:BIB_A203ABE021D0]
Influenza and other respiratory virus infections in solid organ transplant recipients
Manuel O., López-Medrano F., Kaiser L., Welte T., Carrataià J., Cordero E., Hirsch H.H, 2014. Clinical Microbiology and Infection, 20 pp. 102-108.
[URN][DOI][serval:BIB_E0D345D55E11]
 
Influenza vaccination and humoral alloimmunity in solid organ transplant recipients.
Vermeiren P., Aubert V., Sugamele R., Aubert J.D., Venetz J.P., Meylan P., Pascual M., Manuel O., 2014. Transplant International, 27 (9) pp. 903-908.
[DOI][WoS][Pmid][serval:BIB_252EB74C8343]
 
Influenza vaccination in immunocompromised patients: efficacy and safety.
Zbinden D., Manuel O., 2014. Immunotherapy, 6 (2) pp. 131-139.
[DOI][WoS][Pmid][serval:BIB_BD4D2CE03BAB]
 
KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients.
Gonzalez A., Schmitter K., Hirsch H.H., Garzoni C., van Delden C., Boggian K., Mueller N.J., Berger C., Villard J., Manuel O. et al., 2014. Genes and Immunity, 15 (7) pp. 495-499. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E1802E102EC9]
 
Rapid detection of Staphylococcus aureus strains with reduced susceptibility to vancomycin by isothermal microcalorimetry.
Entenza J.M., Bétrisey B., Manuel O., Giddey M., Sakwinska O., Laurent F., Bizzini A., 2014. Journal of Clinical Microbiology, 52 (1) pp. 180-186.
[DOI][WoS][Pmid][serval:BIB_BDAE7703AF53]
 
The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients.
Bibert S., Wojtowicz A., Taffé P., Manuel O., Bernasconi E., Furrer H., Günthard H.F., Hoffmann M., Kaiser L., Osthoff M. et al., 2014. Aids (london, England), 28 (13) pp. 1885-1889. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7F06912C80CF]
2013
Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study.
Manuel O., Husain S., Kumar D., Zayas C., Mawhorter S., Levi M.E., Kalpoe J., Lisboa L., Ely L., Kaul D.R. et al., 2013. Clinical Infectious Diseases, 56 (6) pp. 817-824.
[URN][DOI][WoS][Pmid][serval:BIB_E7C959A7E135]
Clinical Experience with Immune Monitoring for Cytomegalovirus in Solid-Organ Transplant Recipients.
Manuel O., 2013. Current Infectious Disease Reports, 15 (6) pp. 491-496. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8F58E6226C35]
 
European survey on the management of tuberculosis in solid-organ transplant recipients and candidates.
Boillat-Blanco N., Aguado J.M., Aubert J.D., Sester M., Grossi P., Kamar N., Pascual M., Manuel O., ESCMID Study Group of Infection in Compromised Hosts (ESGICH), 2013. Transplant International, 26 (8) pp. e69-e70. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_34D0411C1785]
Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients.
Manuel O., Kralidis G., Mueller N.J., Hirsch H.H., Garzoni C., van Delden C., Berger C., Boggian K., Cusini A., Koller M.T. et al., 2013. American Journal of Transplantation, 13 (9) pp. 2402-2410.
[URN][DOI][WoS][Pmid][serval:BIB_CEF33B24BED3]
 
Prévention des infections chez les voyageurs immunosupprimés [Prevention of infection in immunocompromised travelers].
Zbinden D., D'Acremont V., Manuel O., 2013. Revue Médicale Suisse, 9 (385) pp. 958-962.
[Pmid][serval:BIB_EDA33C95A95F]
 
RNA respiratory viruses in solid organ transplantation.
Manuel O., Estabrook M., T Infectious Diseases Community of Practice, 2013. American Journal of Transplantation, 13 (Suppl. 4) pp. 212-219.
[DOI][WoS][Pmid][serval:BIB_5F2F8454EBE3]
 
Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.
Kotton C.N., Kumar D., Caliendo A.M., Asberg A., Chou S., Danziger-Isakov L., Humar A., Transplantation Society International CMV Consensus Group, 2013. Transplantation, 96 (4) pp. 333-360.
[DOI][WoS][Pmid][serval:BIB_56E090722A2F]
2012
 
Relevance of cohort studies for the study of transplant infectious diseases.
Berger C., Boggian K., Cusini A., van Delden C., Garzoni C., Hirsch H.H., Khanna N., Koller M., Manuel O., Meylan P. et al., 2012/12. Current opinion in organ transplantation, 17 (6) pp. 581-585. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4671170BE51D]
Vaccination de l'immunocompromi et du nouveau-né contre l'hepatite B: faut-il recourir à des équipes dédiées? [Hepatitis B immunization in the neonate and the immunocompromised: time to resort to dedicated teams?]
Boillat Blanco N., Manuel O., Vaudaux B., 2012/04/25. Revue medicale suisse, 8 (338) pp. 901-904. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_49215DD408C7]
 
Antimicrobial Agents
Csajka C., Marchetti O., Manuel O., Decosterd L., Telenti A., 2012. pp. 379-402 dans Anzenbacher P., Zanger U.M. (eds.) Metabolism of Drugs and Other Xenobiotics chap. 14, Wiley-VCH Verlag.
[DOI][serval:BIB_12273AD3B89C]
 
Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy.
Emery V.C., Manuel O., Asberg A., Pang X., Kumar D., Hartmann A., Preiksaitis J.K., Pescovitz M.D., Rollag H., Jardine A.G. et al., 2012. Journal of Clinical Virology, 54 (1) pp. 56-60.
[DOI][WoS][Pmid][serval:BIB_2AF37A51F489]
 
Immunosuppression in hepatitis C virus-infected patients after kidney transplantation.
Manuel O., Baid-Agrawal S., Moradpour D., Pascual M., 2012. Contributions to Nephrology, 176 pp. 97-107.
[WoS][Pmid][serval:BIB_B335B0B01784]
 
Impact of Anti-T-Cell Therapy in the Immunogenicity of Seasonal Influenza Vaccine in Kidney Transplant Recipients.
Orcurto A., Pascual M., Hoschler K., Aubert V., Meylan P., Manuel O., 2012. Transplantation, 94 (6) pp. 630-636. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_50AE47EF9B4C]
 
Influenza vaccination in solid-organ transplant recipients.
Cordero E., Manuel O., 2012. Current Opinion In Organ Transplantation, 17 (6) pp. 601-608. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3CD0770A4F7E]
2011
 
Respiratory Virus
Manuel O., 2011/05. pp. 55-58 dans Kumar D., Humar A. (eds.) The AST Handbook of Transplant Infections chap. 20, Wiley-Blackwell.
[serval:BIB_A19FB5EA236D]
 
Chronic norovirus gastroenteritis in a double hematopoietic stem cell and lung transplant recipient.
Boillat Blanco N., Kuonen R., Bellini C., Manuel O., Estrade C., Mazza-Stalder J., Aubert J.D., Sahli R., Meylan P., 2011. Transplant Infectious Disease, 13 (2) pp. 213-215.
[DOI][Pmid][serval:BIB_AFC324683A49]
Humoral Response to the Influenza A H1N1/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients.
Manuel O., Pascual M., Hoschler K., Giulieri S., Alves D., Ellefsen K., Bart P.A., Venetz J.P., Calandra T., Cavassini M., 2011. Clinical Infectious Diseases, 52 (2) pp. 248-256.
[URN][DOI][WoS][Pmid][serval:BIB_7D018B2FD982]
 
Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipients.
Boillat Blanco N., Pascual M., Venetz J.P., Nseir G., Meylan P.R., Manuel O., 2011. Transplantation, 91 (2) pp. 251-255.
[DOI][WoS][Pmid][serval:BIB_4767174B2A23]
 
Incidence of Infectious Complications in Kidney Transplant Recipients Receiving Induction with Basiliximab, Thymoglobulin or Both
Jankovic J., Pascual M., Venetz J.P., Nseir G., Meylan P., Manuel O., 2011. p. 323 dans ATC 2011, American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
[WoS][serval:BIB_F0F4917D7602]
 
Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients.
Manuel O., Humar A., Berutto C., Ely L., Giulieri S., Lien D., Meylan P.R., Weinkauf J., Pascual M., Nador R. et al., 2011. Journal of Heart and Lung Transplantation, 30 (6) pp. 679-684.
[DOI][WoS][Pmid][serval:BIB_3C1DB6FEB256]
 
QuantiFERON®-CMV assay for the assessment of cytomegalovirus cell-mediated immunity.
Giulieri S., Manuel O., 2011. Expert Review of Molecular Diagnostics, 11 (1) pp. 17-25.
[DOI][WoS][Pmid][serval:BIB_217927B78EB4]
 
Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.
Manuel O., Perrottet N., Pascual M., 2011. Expert Review of Anti-infective Therapy, 9 (11) pp. 955-965.
[DOI][WoS][Pmid][serval:BIB_A9C9384A62F6]
2010
 
A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.
Kumar D., Husain S., Chen M.H., Moussa G., Himsworth D., Manuel O., Studer S., Pakstis D., McCurry K., Doucette K. et al., 2010/04/27. Transplantation, 89 (8) pp. 1028-1033. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CE0A5F479EF3]
 
A Randomized Controlled Trial Comparing Intradermal vs. Intramuscular Influenza Vaccine in Lung Transplant Recipients
Manuel O, Humar A., Berutto C., Lien D., Giulieri S., Weinkauf J., Meylan P.R., Ely L., Pascual M., Nador R. et al., 2010. p. 208 dans 10th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
[WoS][serval:BIB_8A5E2030A4A8]
 
Does Influenza Vaccination Induce De Novo HLA Alloantibody Formation in Transplant Recipients?
Kumar D., Bergeron A., Humar A., Hidalgo L., Manuel O., Campbell P., 2010. pp. 207-208 dans 10th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
[WoS][serval:BIB_D3323F7C848F]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University